Cargando…
TCRP1 induces tamoxifen resistance by promoting the activation of SGK1 in MCF-7 cells
Tamoxifen is widely used as a highly effective drug for treating estrogen-receptor (ER) alpha-positive breast cancer. However, tamoxifen resistance developed during cancer treatment remains a significant challenge. Tongue cancer resistance-related protein1 (TCRP1), which is recognized as a novel dru...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160545/ https://www.ncbi.nlm.nih.gov/pubmed/32323833 http://dx.doi.org/10.3892/or.2020.7577 |